Shares of Joint Corp (NASDAQ:JYNT) have been assigned a consensus broker rating score of 1.50 (Buy) from the two brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company.

Brokerages have set a 1 year consensus price target of $5.50 for the company and are forecasting that the company will post ($0.20) EPS for the current quarter, according to Zacks. Zacks has also given Joint Corp an industry rank of 49 out of 265 based on the ratings given to related companies.

A number of research firms have weighed in on JYNT. Feltl & Co. downgraded Joint Corp from a “strong-buy” rating to a “buy” rating in a report on Friday, June 24th. Zacks Investment Research upgraded Joint Corp from a “sell” rating to a “hold” rating in a report on Tuesday, July 19th. Finally, Maxim Group reduced their target price on Joint Corp from $8.00 to $5.00 and set a “buy” rating on the stock in a report on Friday, July 1st.

In related news, major shareholder Glenhill Advisors Llc purchased 80,069 shares of the company’s stock in a transaction dated Friday, July 1st. The shares were purchased at an average cost of $1.97 per share, with a total value of $157,735.93. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Peter D. Holt purchased 30,000 shares of the company’s stock in a transaction dated Monday, August 29th. The stock was bought at an average cost of $2.66 per share, for a total transaction of $79,800.00. Following the completion of the transaction, the chief executive officer now owns 10,000 shares in the company, valued at $26,600. The disclosure for this purchase can be found here.

Several hedge funds have recently modified their holdings of the company. Sanders Morris Harris Inc. boosted its stake in shares of Joint Corp by 7.0% in the second quarter. Sanders Morris Harris Inc. now owns 2,063,581 shares of the company’s stock worth $4,189,000 after buying an additional 134,753 shares in the last quarter. Boston Partners boosted its stake in shares of Joint Corp by 1.1% in the second quarter. Boston Partners now owns 108,550 shares of the company’s stock worth $220,000 after buying an additional 1,170 shares in the last quarter. Emerald Acquisition Ltd. bought a new stake in shares of Joint Corp during the second quarter worth approximately $108,000. Finally, Skylands Capital LLC boosted its stake in shares of Joint Corp by 12.1% in the second quarter. Skylands Capital LLC now owns 380,734 shares of the company’s stock worth $773,000 after buying an additional 40,950 shares in the last quarter.

Shares of Joint Corp (NASDAQ:JYNT) opened at 2.30 on Wednesday. The company’s 50 day moving average price is $2.40 and its 200-day moving average price is $2.93. Joint Corp has a 12 month low of $1.85 and a 12 month high of $7.90. The stock’s market capitalization is $29.28 million.

Joint Corp (NASDAQ:JYNT) last posted its earnings results on Thursday, August 11th. The company reported ($0.26) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.01. The firm had revenue of $5 million for the quarter, compared to analysts’ expectations of $3.40 million. Equities analysts predict that Joint Corp will post ($0.97) earnings per share for the current year.

About Joint Corp

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

5 Day Chart for NASDAQ:JYNT

Get a free copy of the Zacks research report on Joint Corp (JYNT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Joint Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.